Alternative strategy for overcoming ABO incompatibility [5]

Transplantation

Volumn 83, Issue 9, 2007, Pages 1284-1286

  Kobayashi, Takaaki ^a   Liu, DaGe ^a   Ogawa, Haruko ^b   Miwa, Yuko ^a   Nagasaka, Takaharu ^a   Maruyama, Shoichi ^a   Li, Yu Teh ^c   Onishi, Akira ^d   Kuzuya, Takafumi ^a   Kadomatsu, Kenji ^a   Uchida, Kazuharu ^e   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^e NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BLOOD GROUP A ANTIBODY; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIBODY; BLOOD GROUP B ANTIGEN; CD20 ANTIBODY; IMMUNOGLOBULIN; RECOMBINANT ENDO BETA GALACTOSIDASE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN EXPRESSION; BABOON; BIOPSY; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; COMPLEMENT ACTIVATION; COMPUTER ANALYSIS; DRUG SAFETY; ERYTHROCYTE; ESCHERICHIA COLI; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HISTOGRAM; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY; KIDNEY TRANSPLANTATION; LETTER; LIVER; NONHUMAN; ORGAN DONOR; PLASMAPHERESIS; PRIORITY JOURNAL; TRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; ANIMALS; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; COMPLEMENT ACTIVATION; GLYCOSIDE HYDROLASES; HUMANS; ISOANTIBODIES; PAPIO; RECOMBINANT PROTEINS;

EID: 34248587296     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000260634.85690.c4     Document Type: Letter

References (9)

1. Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089.
2. Stegall MD, Dean PG, Gloor JM. ABO-incompatible kidney transplantation. Transplantation 2004; 78: 635.
3. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004; 77: 403.
4. Anderson KM, Ashida H, Maskos K, et al. A clostridial endo-beta-galactosidase that cleaves both blood groupAand B glycotopes: The first member of a new glycoside hydrolase family, GH98. J Biol Chem 2005; 280: 7720.
5. Narayanan K, Jendrisak MD, Phelan DL, Mohanakumar T. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Transpl Immunol 2006; 15: 187.
6. Jindra PT, Zhang X, Mulder A, etal. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 2006; 82: S33.
7. Liu D, Kobayashi T, Yokoyama I, et al. Enzymatic removal of alphaGal antigen in pig kidneys by ex vivo and in vivo administration of endo-beta-galactosidase C. Xenotransplantation 2002; 9: 228.
8. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplant 2005; 19: 76.
9. Ogawa H, Mohiuddin MM, Yin DP, et al. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation 2004; 77: 366.